Critical illness insurance
"Critical illness insurance must evolve alongside medicine – ensuring protection remains meaningful for decades to come."
Critical illness insurance is gaining renewed strategic importance in today’s healthcare and protection landscape. In this interview, Tim Smith, Head of Protection at Hannover Re UK Life Branch, explains how insurers can design future-ready products that address real customer needs while strengthening portfolio performance. He discusses emerging medical trends, product innovation, and practical approaches to managing complexity and supporting long-term value.
Video: stock.adobe.com
What should insurers understand about critical illness insurance today?
Critical illness insurance provides a lump-sum payment if a policyholder is diagnosed with a serious condition such as cancer, heart attack, or stroke – events that can have a profound and lasting impact on their life.
The benefit is typically not intended to cover direct medical expenses alone, but rather the broader financial consequences that accompany serious illness. These may include loss of income during recovery, childcare costs, home adaptations, or the need for additional care. By alleviating financial pressure, the cover allows families to focus on what matters most during an already difficult time.
The product itself has evolved significantly. Many insurers now offer tiered solutions with varying levels of coverage, often including total permanent disability, partial payments for less severe conditions, and children’s benefits. This flexibility enables insurers to tailor protection to different customer needs and affordability levels.
What is the real-life impact of serious illness, and what is often overlooked?
Let’s take the significant emotional and financial strain it can have on families, for example. Beyond the immediate health concerns, there are often hidden costs – childcare being a good example – that can escalate quickly when normal routines are disrupted.
Reducing this financial burden removes a major source of stress at a time that is naturally challenging for everyone involved. It enables families to concentrate their energy on recovery and supporting one another.
With healthcare costs rising, how does critical illness help policyholders access advanced treatment?
Even in markets with strong public healthcare systems, the gap between standard treatment pathways and advanced medical options continues to widen – particularly in areas such as oncology.
Because critical illness provides a guaranteed lump sum, policyholders gain financial flexibility at the point of diagnosis. Whether funding private treatment, accessing newer therapies, or covering associated expenses, the benefit ensures individuals can pursue the care most appropriate to their circumstances.
Health insurance does not always keep pace with medical innovation; critical illness cover can help bridge that gap.
The term 'critical' can be subjective. What criteria are used to define a critical illness in insurance?
This is one of the most complex aspects of product design. Critical illness generally refers to conditions that are life-changing, highly stressful, or potentially life-threatening. Translating this broad understanding into clear policy definitions, however, is far from straightforward.
Definitions must strike a careful balance – avoiding the exclusion of genuinely serious conditions while ensuring that claims are triggered appropriately. Skin cancer is a useful example: while some cases are aggressive and life-altering, others are easily treated with minimal long-term impact. Capturing that spectrum accurately is essential to maintaining both fairness and sustainability.
Tim leads Hannover Re’s protection proposition in the UK, from business development and pricing to inforce management, across both traditional reinsurance and capital-focussed transactions. An actuary by profession, he has held various roles across the pensions and life insurance industries and brings experience from a number of global markets.
"Definitions must strike a careful balance – avoiding the exclusion of genuinely serious conditions while ensuring that claims are triggered appropriately."
Why should critical illness products be part of an insurer’s portfolio?
Critical illness can complement life cover effectively. Customers often purchase both, and advisers frequently place the covers with a single insurer to streamline underwriting and improve affordability. Offering critical illness cover can therefore broaden an insurer’s addressable market while enhancing customer convenience.
Importantly, it also creates opportunities for differentiation. While life cover can be difficult to innovate, critical illness allows insurers to refine definitions, expand coverage, and develop distinctive propositions aligned with evolving health risks.
A streamlined underwriting journey further enhances the customer experience while improving placement rates.
What are the biggest challenges in designing critical illness products today?
Critical illness insurance must evolve alongside medicine – ensuring protection remains meaningful for decades to come. Innovations such as blood tests capable of detecting cancers earlier, along with continued progress in genetic testing, are reshaping how conditions are identified and managed. Designing products with this forward view, supported by continuous horizon scanning, helps ensure they stay relevant for future policyholders.
At the same time, insurers must remain mindful of behavioural implications. Product structures should avoid unintentionally encouraging unnecessary medical intervention while still providing meaningful protection.
Can you share an example of innovation in critical illness product design?
We were involved in developing a product that focused more on the prognosis of the patient rather than solely on diagnosis. In traditional critical illness products, a payout is typically triggered once a diagnosis meets predefined criteria. However, not all diagnoses have the same impact on a person’s life. A prognosis-based approach introduces an additional layer by considering factors such as disease severity, likely progression, and whether treatment is required.
Prostate cancer illustrates why this distinction matters. Some cases are low risk and may never require treatment, while others involve surgery and a significant recovery period. By differentiating between these scenarios – for example, through tiered or conditional benefits – the product can better align payouts with the actual financial impact on the policyholder.
This allows insurers to meaningfully support customers where it is genuinely needed, while maintaining affordability and long-term sustainability of the product.
With a strong technical background, Tim is passionate about closing protection gaps by designing products that sustainably meet customers’ needs. Outside of his role at Hannover Re, he enjoys spending time with family and friends, as well as playing golf and tennis (though perhaps more enthusiastically than skilfully).
"Through close collaboration, we can adapt proven approaches to local market dynamics, supporting the development of sustainable products that resonate with target customers."
Are there lessons insurers should keep in mind when refining their products?
Simplicity is critical. Policy language can easily become complex when defining medical conditions, yet advisers and policyholders must clearly understand what is being purchased.
Claims experience is an equally valuable source of insight. Observations from real claims help identify ambiguities in definitions and inform continuous product refinement, strengthening clarity and long-term sustainability.
How can insurers approach entering and developing in the critical illness market?
Engaging with an experienced reinsurance partner is a strong starting point. We bring global expertise and market insight that help insurers navigate complexity and accelerate product development.
At Hannover Re, this is underpinned by a deep understanding of risk. Dedicated research teams continuously monitor trends in diagnosis and treatment, enabling a forward-looking approach to product design. At the same time, a strong client and consumer focus ensures that solutions are aligned with market needs and remain relevant over the long term.
Through close collaboration, we can adapt proven approaches to local market dynamics, supporting the development of sustainable products that resonate with target customers.
Finally, what makes working in this field particularly rewarding for you?
For me, it is the opportunity to help create protection that genuinely supports people when they need it most. Critical illness insurance is about more than financial replacement – it enables policyholders to focus on recovery and their families when life is unexpectedly disrupted. Helping insurers design products that remain relevant as medicine advances is both intellectually challenging and deeply meaningful.

Tim Smith Head of Protection Hannover Re UK Life Branch Tel.: +44 20 3206-1811 Mail: tim.smith@hannover-re.com
Podcast
Interested in more?
In this episode of RePlay by Hannover Re, Tim Smith expands on critical illness insurance:
Listen here

ReCent Perspectives
For more expert insights, explore previous editions of our ReCent Perspectives newsletter:

Notification Service
To get notified when a new edition of our ReCent newsletters is available, subscribe here:

RePlay by Hannover Re
Tune in to our podcast featuring expert interviews exploring the complexities of life and health (re)insurance:
If you need further information or would like to send us feedback, please feel free to get in touch.
* The information provided in this document does in no way whatsoever constitute legal, accounting, tax or other professional advice. While Hannover Rück SE has endeavoured to include in this document information it believes to be reliable, complete and up-to-date, the company does not make any representation or warranty, express or implied, as to the accuracy, completeness or updated status of such information. Therefore, in no case whatsoever will Hannover Rück SE and its affiliated companies or directors, officers or employees be liable to anyone for any decision made or action taken in conjunction with the information in this document or for any related damages.
Hannover Rück SE © 2024